imugene's science series: pd1-vaxx | b cell immunotherapy
Published 2 years ago • 1.7K plays • Length 32:59Download video MP4
Download video MP3
Similar videos
-
0:37
imugene's science series: pd1-vaxx (intro)
-
4:27
imugene pd1 vaxx 1080p
-
6:12
imugene @ aacr 2020: pd1-vaxx (imu-201) phase 1 briefing
-
4:00
first patient dosed in imugene's pd1-vaxx combination trial
-
6:29
imugene finishes phase 1a monotherapy dose escalation of pd1 vaxx
-
9:16
imugene ceo leslie chong presents at wholesale investor's virtual showcase july 2020
-
6:16
imugene's new cancer therapy cd19 (oncarlytics) considered the 'holy grail'
-
4:07
combination car t oncolytic virus immunotherapy kills tumors
-
13:14
s.biomedics
-
4:54
imugene reports promising results in phase 1b trial for azer-cel in dlbcl
-
5:04
imugene (asx:imu) | jmm & éthica capital innovation interview \ may 2024
-
5:33
imugene ceo says fda ind approval for pd1-vaxx is 'huge news' for the company
-
20:37
imugene (asx: imu) – the ‘holy grail’ of cancer treatment…?! | asx ceo interview 🚀📈
-
27:13
imugene investor webinar: mast study update
-
18:08
asx/ausbiz biotech unlocked with imugene ceo leslie chong
-
26:56
investor presentation post asx news: imugene and eureka therapeutics oncarlytics collaboration
-
24:02
imugene forges development path of immunotherapies and cancer-killing virus
-
7:40
imugene limited (asx: imu) emergence 2024: presentation by leslie chong, managing director and ceo
-
20:57
imugene (asx: imu) - discussing imu's 2022 biotech opportunity
-
6:15
imugene ceo hails clinical milestone for her-vaxx cancer immunotherapy
-
26:23
imugene (asx:imu) presentation, nwr virtual healthcare conference
-
16:12
a clinical stage immuno-oncology company.